Home › Nodality Inc. Presents Data From Immuno-Oncology Program Applying Company's Novel Single Cell Network Profiling (SCNP) Platform
 

Keywords :   


Nodality Inc. Presents Data From Immuno-Oncology Program Applying Company's Novel Single Cell Network Profiling (SCNP) Platform

2015-02-27 01:59:32| drugdiscoveryonline Home Page

Nodality, Inc., which is focused on solving drug development challenges, recently announced research results from its lead immuno-oncology efforts based on applications of the Company’s Single Cell Network Profiling (SCNP) technology

Tags: data program single network

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Producers to be paid grid premiums for AngusLink beef scores
18.05This Week in Agribusiness, May 18, 2024
18.05This Week in Agribusiness, May 18, 2024
18.05Unpaid carers being forced to repay 250m to DWP
18.05Weekly Recap: Hempel, Axalta, KANSAI HELIOS Top This Weeks Stories
18.05Eastern North Pacific Tropical Weather Outlook
More »